OrentlicherD. and CaplanA., “The Pain Relief Promotion Act of 1999: A Serious Threat to Palliative Care,”JAMA283, no. 2 (2000): 255–258; Pain Relief Promotion Act of 1999, HR 2260, 106th Congress.
2.
RichB. A., “Oregon versus Ashcroft: Pain Relief, Physician-Assisted Suicide, and the Controlled Substances Act,”Pain Medicine3, no. 44 (2002): 353–360; WerthJ., “Reinterpreting the CSA: Predictions for the Effect on Pain Relief,”Behavioral Sciences and the Law20 (2002): 287–305.
3.
MeiselA. and CerminaraK. L., The Right to Die, 3rd ed. (New York: Aspen Publishers, 2004): at 12–37; HillyardD. and DombrinkJ., Dying Right: The Death with Dignity Movement (New York: Routledge, 2001): at 220; Washington v. Glucksberg, 521 U.S. 702 (1997); Vacco v. Quill, 521 U. S. 793 (1997).
4.
VolkerD., “Methodological Issues Associated with Studying an Illegal Act: Assisted Dying,”Advances in Nursing Science27, no. 2 (2004): 117–128 at 117; MeiselA. and CerminaraK. L., The Right to Die, 3rd ed. (New York: Aspen Publishers, 2004): At 12–35.
5.
EmanuelE. J., “Euthanasia and Physician-Assisted Suicide: A Review of the Empirical Data from the United States.”Archives of Internal Medicine162 (2002): 142–152; MeiselA. and CerminaraK. L., The Right to Die, 3rd ed. (New York: Aspen Publishers, 2004): At 12–39.
6.
MeiselA. and CerminaraK. L., The Right to Die (3rd Ed.) (New York: Aspen Publishers, 2004): at 12–40, 12–47; ChochinovH. M. and WilsonK. G., “The Euthanasia Debate: Attitudes, Practices, and Psychiatric Considerations,”Canadian Journal of Psychiatry40, no. 10 (1995): 593–602.
7.
The raw data for this article stems from my earlier research (ZieglerS. J., Prosecutors, Palliative Medicine, and Physician-Assisted Death: An Empirical Assessment of the Likelihood of Prosecution Stemming from Opioid and Non-Opioid Administrations, unpublished Ph.D. dissertation, Washington State University [2003]).
8.
ZieglerS. J. and LovrichN. P., “Pain Relief, Prescription Drugs, and Prosecution: A Four-State Survey of Chief Prosecutors,”Journal of Law, Medicine & Ethics31, no. 1 (2003): 75–100.
9.
SpohnC.BeichnerD., and Davis-FrenzelE., “Prosecutorial Justifications for Sexual Assault Case Rejection: Guarding the Gateway to Justice,”Social Problems48, no. 2 (2001): 206–235; AlbonettiC. A., “Prosecutorial Discretion: The Effects of Uncertainty,”Law & Society Review21, no. 2 (1987): 291–313; JacobyJ. E., The American Prosecutor: A Search for Identity, (Lexington, MA: Lexington Books, 1980).
10.
JacksonR., “The Federal Prosecutor,”Journal of the American Judicature Society24 (1940): 18–20.
11.
AlpersA., “Criminal Act or Palliative Care? Prosecutions Involving the Care of the Dying,”Journal of Law, Medicine, & Ethics26, no. 4 (1998): 308–331 at 308.
12.
VolkerD., “Methodological Issues Associated with Studying an Illegal Act: Assisted Dying,”Advances in Nursing Science27, no. 2 (2004): 117–128 at 117; MeiselA. and CerminaraK. L., The Right to Die, 3rd ed. (New York: Aspen Publishers, 2004): At 12–11, 12–35; ReidS. T., Criminal Law, 6th ed. (New York: McGraw-Hill, 2004): At 233.
13.
ReidS. T., Criminal Law, 6th ed. (New York: McGraw-Hill, 2004): at 227–235.
14.
LiederbachJ.CullenF. T.SundtJ. L., and GeisG., “The Criminalization of Physician Violence: Social Control in Transformation,”Justice Quarterly18, no. 1 (2001): 141–170; AlpersA., “Criminal Act or Palliative Care? Prosecutions Involving the Care of the Dying,”Journal of Law, Medicine, & Ethics26, no. 4 (1998): 308–331 at 309.
15.
AlpersA., “Criminal Act or Palliative Care? Prosecutions Involving the Care of the Dying,”Journal of Law, Medicine, & Ethics26, no. 4 (1998): 308–331; MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095 at 1094; ZieglerS. J. and LovrichN. P., “Pain Relief, Prescription Drugs, and Prosecution: A Four-State Survey of Chief Prosecutors,”Journal of Law, Medicine & Ethics31, no. 1 (2003): 75–100.
16.
AlpersA., “Criminal Act or Palliative Care? Prosecutions Involving the Care of the Dying,”Journal of Law, Medicine, & Ethics26, no. 4 (1998): 308–331; MeiselA. and CerminaraK. L., The Right to Die, 3rd ed. (New York: Aspen Publishers, 2004): At 12–41; BucyP. H., “The Poor Fit of Traditional Evidentiary Doctrine and Sophisticated Crime: An Empirical Analysis of Health Care Fraud Prosecutions,”Fordham Law Review63 (1994): 383–528 at 386; ZieglerS. J. and LovrichN. P., “Pain Relief, Prescription Drugs, and Prosecution: A Four-State Survey of Chief Prosecutors,”Journal of Law, Medicine & Ethics31, no. 1 (2003): 75–100.
17.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095.
18.
AlpersA., “Criminal Act or Palliative Care? Prosecutions Involving the Care of the Dying,”Journal of Law, Medicine, & Ethics26, no. 4 (1998): 308–331.
19.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095.
20.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095.
21.
AlpersA., “Criminal Act or Palliative Care? Prosecutions Involving the Care of the Dying,”Journal of Law, Medicine, & Ethics26, no. 4 (1998): 308–331.
22.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095.
23.
DillmanD. A., Mail and Internet Surveys: The Tailored Design Method, 2nd ed. (New York: John Wiley and Sons, Inc., 2000).
24.
Washington State University, Pullman, Washington
25.
Purdue University, West Lafayette, Indiana.
26.
Further details of the methods employed can be found in ZieglerS. J. and LovrichN. P., “Pain Relief, Prescription Drugs, and Prosecution: A Four-State Survey of Chief Prosecutors,”Journal of Law, Medicine & Ethics31, no. 1 (2003): 75–100.
27.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095.
28.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095.
29.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095 at 1094.
30.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095 at 1092.
31.
ZieglerS. J. and LovrichN. P., “Pain Relief, Prescription Drugs, and Prosecution: A Four-State Survey of Chief Prosecutors,”Journal of Law, Medicine & Ethics31, no. 1 (2003): 75–100.
32.
ZieglerS. J. and LovrichN. P., “Pain Relief, Prescription Drugs, and Prosecution: A Four-State Survey of Chief Prosecutors,”Journal of Law, Medicine & Ethics31, no. 1 (2003): 75–100.
33.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095 at 1092.
34.
See, e.g., MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095 at 1094.
35.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095.
36.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095 at 1093.
37.
EmanuelE. J., “Euthanasia and Physician-Assisted Suicide: A Review of the Empirical Data from the United States”, Archives of Internal Medicine162 (2002): 142–152; MeiselA. and CerminaraK. L., The Right to Die, 3rd ed. (New York: Aspen Publishers, 2004): At 12–40.
38.
LiederbachJ.CullenF. T.SundtJ. L., and GeisG., “The Criminalization of Physician Violence: Social Control in Transformation,”Justice Quarterly18, no. 1 (2001): 141–170; AlpersA., “Criminal Act or Palliative Care? Prosecutions Involving the Care of the Dying,”Journal of Law, Medicine, & Ethics26, no. 4 (1998): 308–331.
39.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095, at 1093, 1095.
40.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095, at 1095.
41.
DillmanD. A., Mail and Internet Surveys: The Tailored Design Method, 2nd ed. (New York: John Wiley and Sons, Inc., 2000).
42.
AlpersA., “Criminal Act or Palliative Care? Prosecutions Involving the Care of the Dying,”Journal of Law, Medicine, & Ethics26, no. 4 (1998): 308–331 at 311.
43.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095, at 1092.
44.
MeiselA.JerniganJ. C., and YoungnerS. J., “Prosecutors and End-of-Life Decision Making,”Archives of Internal Medicine159, no. 10 (1999): 1089–1095.
45.
CoxS. J., “Prosecutorial Discretion: An Overview,”American Criminal Law Review13, no. 3 (1976): 383–434, at 391.
46.
SpohnC.BeichnerD., and Davis-FrenzelE., “Prosecutorial Justifications for Sexual Assault Case Rejection: Guarding the Gateway to Justice,”Social Problems48, no. 2 (2001): 206–235; FrohmannL., “Convictability and Discordant Locales: Reproducing Race, Class, and Gender Ideologies in Prosecutorial Decisionmaking,”Law & Society Review31, no. 3 (1997): 531–555; CoxS. J., “Prosecutorial Discretion: An Overview,”American Criminal Law Review13, no. 3 (1976): 383–434; ThomasC. W. and FitchW. A., “Prosecutorial Decision Making,”American Criminal Law Review13, no. 3 (1976): 507–559; AlbonettiC. A., “Prosecutorial Discretion: The Effects of Uncertainty,”Law & Society Review21, no. 2 (1987): 291–313; MillerF. W., Prosecution: The Decision to Charge a Suspect with a Crime: The Report of the American Bar Foundation's Survey of the Administration of Criminal Justice in the United States (Boston: Little, Brown and Company, 1969).
47.
See also ZieglerS. J. and LovrichN. P., “Pain Relief, Prescription Drugs, and Prosecution: A Four-State Survey of Chief Prosecutors,”Journal of Law, Medicine & Ethics31, no. 1 (2003): 75–100.
48.
FrohmannL., “Convictability and Discordant Locales: Reproducing Race, Class, and Gender Ideologies in Prosecutorial Decisionmaking,”Law & Society Review31, no. 3 (1997): 531–555; JacobyJ. E., The American Prosecutor: A Search for Identity (Lexington, MA: Lexington Books, 1980); ColeG. F., “The Decision to Prosecute,”Law and Society Review4, no. 3 (1970): 331–343; JacobyJ. E., “The Charging Policies of Prosecutors,” in The Prosecutor, McDonaldW. F., ed. (Beverly Hills, CA: Sage Publications, 1979): 75–95.
49.
FinkelN. J.HurabiellM. L., and HughesK. C., “Right to Die, Euthanasia, and Community Sentiment,”Law and Human Behavior17, no. 5 (1993): 487–506.
50.
JesilowP. D.PontellH. N., and GeisG., “Medical Criminals: Physicians and White-Collar Offenses,”Justice Quarterly2 (1985): 149–65.
51.
MeiselA. and CerminaraK. L., The Right to Die, 3rd ed. (New York: Aspen Publishers, 2004): at 12–50.